Please help us in welcoming Dr. William Bensinger, the newest addition to our NWMS Team!
Dr. Bensinger has served as the Director of the Autologous Stem Cell Transplant Program at Fred Hutchinson Cancer Research Center and was a Professor of Medicine at the University of Washington.
Dr. Bensinger received his undergraduate and medical education at Northwestern University in Chicago. He worked for two years at the National Cancer Institute in Bethesda, MD. in the field of cancer virology before moving to the University of Washington for completion of internal medicine residency and completion of subspecialty training in medical oncology.
Dr. Bensinger has broad experience in clinical trials with more than 100 such trials, including newer immunotherapies with Car T cells and bi-specific molecules.
In 2015, Dr. Bensinger was named a Newsweek Top Cancer Doctor for multiple myeloma and stem cell transplantation. He has published more than 380 articles in journals, books and monographs in the field of stem cell transplantation and on the subjects of mobilization, collection and transplantation of autologous and allogeneic stem cells, especially as it relates to the treatment of multiple myeloma. Other publications include the use of CD34 selected stem cells and innovative transplant regimens. He holds several patents including one as co-inventor of the avidin-biotin bead selection system. He is formerly the vice-chair of the NCCN multiple myeloma guidelines committee and co-chair of the NCCN cancer related infection guidelines committee.
We are incredibly honored and so excited to have Dr. Bensinger joining our team here at NWMS beginning this April.